ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Opinion Article

Yellow fever in the Americas: the growing concern about new epidemics

[version 1; peer review: 1 approved, 1 approved with reservations]
PUBLISHED 30 Mar 2017
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Emerging Diseases and Outbreaks gateway.

Abstract

Yellow fever (YF) is a haemorrhagic viral disease with a high case fatality rate. It is considered a reemerging infectious disease of remarkable importance. During the last outbreaks in Angola (2015-2016) and Brazil (2016-2017), many cases of YF emerged despite high YF vaccination coverage, increasing the risk of major epidemics in the Americas. Several factors, including the vast border and migratory status of Brazil, the widespread distribution of Aedes mosquitoes and the lack of efficient health policies and surveillance systems, favour this complex epidemiological scenario of reemergence. Therefore, mass vaccination of the population at risk, public health awareness and preparedness are urgently needed in this region. This article describes the current global epidemiological situation of YF, focusing especially on the Americas, as well the risk and vulnerabilities in the region that would be of concern for major expansion to other countries apart from Brazil.

Keywords

yellow fever, epidemics, Africa, Americas, Brazil, vector-borne disease, arbovirus,

Introduction

Yellow fever (YF) is a haemorrhagic viral, vector-borne disease with a high case fatality rate (CFR), spread by infected mosquitoes. It has reappeared as a threat to global public health, evidenced by new epidemics in several countries in Africa and South America through autochthonous transmission, and in Asia with imported cases1. In Asia, but also Europe and North America, Nevertheless, potential spreads beyond the borders of the endemic countries is a matter of global concern. Currently, there are around 1 billion people, from 49 endemic countries, that are considered at risk1,2.

Recent outbreaks

Although relatively wide scale YF vaccination has been applied, a growing number of outbreaks have been documented in several African countries in the last decade. The most recent outbreak occurred in Angola, resulting in 7,344 suspected cases, 962 laboratory-confirmed cases and 137 deaths (with a CFR of 14.2%), and lasting from December 2015 to October 20162. In addition to spread of YF by autochthonous transmission, confirmed imported cases of YF were identified in China and Kenya13. Other countries, such as Chad, Ghana and Guinea have also reported outbreaks or sporadic cases not linked to the outbreak in Angola13.

The concern raised from Brazil

Even though no new cases have been confirmed since the last year in Angola, the global threat continues, now with its epicentre in South America. An ongoing outbreak of YF has started in Brazil since December 1, 2016. Up to February 22, 2017, a total of 1,336 cases of YF infection have been reported (292 laboratory confirmed, 920 suspected and 124 ruled out), resulting in 215 deaths (101 confirmed, 109 suspected, 5 ruled out) across six states of the country (Bahia, Espírito Santo, Minas Gerais, Rio Grande do Norte, São Paulo and Tocantins). The current CFR is 35% (from confirmed cases) and 12% (from suspected cases)3.

The geographical spread of the cases in Brazil has led to major concern, because cases are no longer being reported just in the jungle, but also in the most densely populated cities and states such as Minas Gerais and São Paulo. Fortunately, these regions have a long history of high YF vaccination coverage in young people, in contrast with the low vaccination rates in other major urban centres of Brazil4.

Although the epidemiology and clinical manifestations of YF should be familiar to healthcare workers in endemic countries, where clinical manifestations can overlap with other acute viral haemorrhagic fevers and other etiologies of the febrile syndrome, a rapid spread of misinformation about this harmful disease in social media and a lack of online training for healthcare workers has been reported in the recent outbreak of 2016–2017 in the Americas5,6. In addition to limited health resources, this highlights that early identification could be a challenge in Latin America, as has been observed in the past with Zika and chikungunya virus outbreaks in this region, particularly in countries such as Brazil and Colombia7,8.

Conclusions

There seems to be an almost imminent risk of YF outbreaks turning into a large epidemic9. Unvaccinated travelers heading to the affected states in Brazil are at risk of spreading the virus in to areas where YF risk factors (human susceptibility, prevalence of competent vector, and animal reservoirs) are present. Ecological factors and enzootics would promote the necessary spillover that would lead to an epidemic1012. Moreover, the vast border of Brazil, with 10 neighboring countries/territories (Uruguay, Argentina, Paraguay, Bolivia, Peru, Colombia, Venezuela, Guyana, Suriname and French Guiana), the lack of efficient health policies and surveillance systems, and the distribution of Aedes vectors (as well the uncontrollable sylvatic vector species in the genus Haemagogus and Sabethes), raise the possibility of the widespread YF throughout the Americas, including the USA. The USA has suitable conditions for autochthonous cases in areas such as South Florida, where Aedes albopictus is present and has been linked to transmission of dengue virus (another flavivirus), chikungunya and possibly Zika.

Mass vaccination of the at-risk population13, and public health awareness and preparedness is urgently needed to control the current 2016–2017 outbreak in Brazil and prevent a possible epidemic related to this deadly disease. More studies, as well as new innovative strategies for vector control (e.g. involving community participation), early prevention (e.g. sampling in risk areas to look for asymptomatic subjects), warning and enhanced surveillance (using smart phones), are necessary in order to improve the scenario of this reemerging arboviral threat14,15.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 30 Mar 2017
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Ortiz-Martínez Y, Patiño-Barbosa AM and Rodriguez-Morales AJ. Yellow fever in the Americas: the growing concern about new epidemics [version 1; peer review: 1 approved, 1 approved with reservations]. F1000Research 2017, 6:398 (https://doi.org/10.12688/f1000research.11280.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 30 Mar 2017
Views
13
Cite
Reviewer Report 18 Apr 2017
Paola Barato, Veterinary Pathobiology Group, Laboratory of Veterinary Pathology, Institute of Biotechnology, National University of Colombia, Bogotá, Colombia;  CEO and Scientific Director, CORPAVET, Bogotá, Colombia 
Approved
VIEWS 13
In general, it is an interesting and well written opinion article. Some comments:

TITLE: Okay.

ABSTRACT: Okay.

INTRODUCTION:
1. I consider it to be desirable to include in the introduction ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Barato P. Reviewer Report For: Yellow fever in the Americas: the growing concern about new epidemics [version 1; peer review: 1 approved, 1 approved with reservations]. F1000Research 2017, 6:398 (https://doi.org/10.5256/f1000research.12169.r21389)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 19 Apr 2017
    Alfonso Rodriguez-Morales, Fundación Universitaria Autónoma de las Américas, Colombia
    19 Apr 2017
    Author Response
    Dear Dr. Barato

    Thank you very much for your valuable assessment and comments. Regard the specific comments:

    INTRODUCTION:
    1. I consider it to be desirable to include in the introduction the name of
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 19 Apr 2017
    Alfonso Rodriguez-Morales, Fundación Universitaria Autónoma de las Américas, Colombia
    19 Apr 2017
    Author Response
    Dear Dr. Barato

    Thank you very much for your valuable assessment and comments. Regard the specific comments:

    INTRODUCTION:
    1. I consider it to be desirable to include in the introduction the name of
    ... Continue reading
Views
17
Cite
Reviewer Report 04 Apr 2017
Jean-Paul J. Gonzalez, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA 
Juergen Richt, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA 
Approved with Reservations
VIEWS 17
Title: 
Although the title is appropriate and clearly leads to the risk of YF re-emergence in the Americas, the manuscript is more centred to South and eventually Central Americas. Also, for this matter (i.e. maintain the title), the authors ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Gonzalez JPJ and Richt J. Reviewer Report For: Yellow fever in the Americas: the growing concern about new epidemics [version 1; peer review: 1 approved, 1 approved with reservations]. F1000Research 2017, 6:398 (https://doi.org/10.5256/f1000research.12169.r21529)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 04 Apr 2017
    Alfonso Rodriguez-Morales, Fundación Universitaria Autónoma de las Américas, Colombia
    04 Apr 2017
    Author Response
    Dear Drs. Gonzalez and Richt

    Thanks for you valuable comments. The first thing that should be pointed out is that this is not a Review Article, is a short ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 04 Apr 2017
    Alfonso Rodriguez-Morales, Fundación Universitaria Autónoma de las Américas, Colombia
    04 Apr 2017
    Author Response
    Dear Drs. Gonzalez and Richt

    Thanks for you valuable comments. The first thing that should be pointed out is that this is not a Review Article, is a short ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 30 Mar 2017
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.